Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Dermatology|July 23, 2025
Drug survival, effectiveness, and safety of risankizumab for moderate-to-severe psoriasis for up to 4 yearsLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Dermatology (Basel, Switzerland)|November 19, 2015
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell LymphomasPaolo Fava, Massimiliano Bergallo, Chiara Astrua, et al.
Journal of Clinical Medicine|September 14, 2024
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life ExperienceGabriele Roccuzzo, Nicole Macagno, Pietro Grignani, et al.
Disease Markers|March 7, 2022
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry StudyPietro Quaglino, Mauro Novelli, Paolo Fava, et al.
Cancers|September 14, 2024
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected MelanomaGabriele Roccuzzo, Paolo Fava, Chiara Astrua, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2017
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the diseaseAlessandro Pileri, Claudio Agostinelli, Maurizio Sessa, et al.
Scientific Reports|September 26, 2020
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patientsDavide Zocco, Simona Bernardi, Mauro Novelli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 15, 2017
Treatment of metastatic melanoma: a multidisciplinary approachPaolo Fava, Chiara Astrua, Martina Sanlorenzo, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
International Journal of Dermatology|April 12, 2024
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patientsGianluca Nazzaro, Andrea Carugno, Paolo Bortoluzzi, et al.
Pageof 3